Orion Oyj Class B (ORNBV)

Overview

Orion Oyj is a prominent pharmaceutical company that engages in the development, manufacturing, and marketing of human and veterinary pharmaceuticals, alongside active pharmaceutical ingredients (APIs). Established in 1917, the company has a global presence with operations spanning Finland, Scandinavia, the rest of Europe, North America, and other international markets. Orion Oyj's product portfolio includes prescription drugs, self-care products, and veterinary drugs, as well as providing contract manufacturing services. The company has formed strategic partnerships, such as with Propeller Health to integrate its Easyhaler(R) product portfolio and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. Its headquarter is located in Espoo, Finland.

Products and Services

• Prescription Drugs and Self-care Products

  Orion Oyj offers an array of medications for a variety of conditions. Nubeqa is targeted for prostate cancer treatment, Precedex, Dexdor, and Precedex for sedation in medical procedures, and Burana for inflammatory pain. The Divina series addresses menopausal symptoms, Trexan for rheumatoid arthritis and cancer, and Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease. In addition, Biosimilars provide alternatives for rheumatoid arthritis and inflammatory bowel diseases, Simdax treats acute decompensated heart failure, and Fareston for breast cancer. Orion also offers solutions for asthma and chronic obstructive pulmonary disease (COPD) with its Easyhaler products like Salmeterol/fluticasone, Budesonide/formoterol, Formoterol, Budesonide, Beclomet, and Buventol.

• Veterinary Drugs

  For animal health, Orion develops and markets a range of medications including Bonqat for feline hypertension, Clevor for induced vomiting in dogs, and a selection of sedatives and anesthetics such as Domosedan, Domitor, Antisedan, Dexdomitor, and Domosedan Gel. Sileo, designed for noise aversion in dogs, and Tessie, address other veterinary needs. Orion also acts as a distributor for veterinary drugs produced by other global companies, broadening its portfolio.

• Active Pharmaceutical Ingredients (APIs)

  Orion Oyj supplies APIs for both generic compounds and proprietary products. Through its sophisticated manufacturing capabilities, the company provides contract manufacturing services to partners globally, specializing in high-quality pharmaceutical ingredients.

• Partnerships and Collaborations

  Noteworthy partnerships include the collaboration with Propeller Health to integrate smart technology with Orion’s Easyhaler(R) line for improved treatment of respiratory conditions. Furthermore, Orion's agreement with Amneal Pharmaceuticals, Inc. facilitates the commercialization of Amneal's generic products, expanding Orion's portfolio and strengthening its market position.